605 NHS-IL12 plus Entinostat combination effectively targets anti-PD-1/PD-L1 checkpoint resistant murine tumors harboring MHC Class I and antigen processing machinery deficiency
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1828920242884050944 |
|---|---|
| author | Jeffrey Schlom Sofia Gameiro Christine Minnar Paul Chariou Kristin Hicks |
| author_facet | Jeffrey Schlom Sofia Gameiro Christine Minnar Paul Chariou Kristin Hicks |
| author_sort | Jeffrey Schlom |
| collection | DOAJ |
| first_indexed | 2024-12-13T21:42:54Z |
| format | Article |
| id | doaj.art-3bde5989cb664b0d8ec5568bf377f6b2 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-12-13T21:42:54Z |
| publishDate | 2021-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-3bde5989cb664b0d8ec5568bf377f6b22022-12-21T23:30:30ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262021-11-019Suppl 210.1136/jitc-2021-SITC2021.605605 NHS-IL12 plus Entinostat combination effectively targets anti-PD-1/PD-L1 checkpoint resistant murine tumors harboring MHC Class I and antigen processing machinery deficiencyJeffrey Schlom0Sofia Gameiro1Christine Minnar2Paul Chariou3Kristin Hicks4Laboratory of Tumor Immunology and Biology, National Cancer Institute, Bethesda, Maryland, USAAff1 NCI/CCR/LTIB Bethesda MD USANational Cancer Institute, Bethesda, MD, USANational Cancer Institute, Bethesda, MD, USANational Cancer Institute, Bethesda, MD, USA |
| spellingShingle | Jeffrey Schlom Sofia Gameiro Christine Minnar Paul Chariou Kristin Hicks 605 NHS-IL12 plus Entinostat combination effectively targets anti-PD-1/PD-L1 checkpoint resistant murine tumors harboring MHC Class I and antigen processing machinery deficiency Journal for ImmunoTherapy of Cancer |
| title | 605 NHS-IL12 plus Entinostat combination effectively targets anti-PD-1/PD-L1 checkpoint resistant murine tumors harboring MHC Class I and antigen processing machinery deficiency |
| title_full | 605 NHS-IL12 plus Entinostat combination effectively targets anti-PD-1/PD-L1 checkpoint resistant murine tumors harboring MHC Class I and antigen processing machinery deficiency |
| title_fullStr | 605 NHS-IL12 plus Entinostat combination effectively targets anti-PD-1/PD-L1 checkpoint resistant murine tumors harboring MHC Class I and antigen processing machinery deficiency |
| title_full_unstemmed | 605 NHS-IL12 plus Entinostat combination effectively targets anti-PD-1/PD-L1 checkpoint resistant murine tumors harboring MHC Class I and antigen processing machinery deficiency |
| title_short | 605 NHS-IL12 plus Entinostat combination effectively targets anti-PD-1/PD-L1 checkpoint resistant murine tumors harboring MHC Class I and antigen processing machinery deficiency |
| title_sort | 605 nhs il12 plus entinostat combination effectively targets anti pd 1 pd l1 checkpoint resistant murine tumors harboring mhc class i and antigen processing machinery deficiency |
| work_keys_str_mv | AT jeffreyschlom 605nhsil12plusentinostatcombinationeffectivelytargetsantipd1pdl1checkpointresistantmurinetumorsharboringmhcclassiandantigenprocessingmachinerydeficiency AT sofiagameiro 605nhsil12plusentinostatcombinationeffectivelytargetsantipd1pdl1checkpointresistantmurinetumorsharboringmhcclassiandantigenprocessingmachinerydeficiency AT christineminnar 605nhsil12plusentinostatcombinationeffectivelytargetsantipd1pdl1checkpointresistantmurinetumorsharboringmhcclassiandantigenprocessingmachinerydeficiency AT paulchariou 605nhsil12plusentinostatcombinationeffectivelytargetsantipd1pdl1checkpointresistantmurinetumorsharboringmhcclassiandantigenprocessingmachinerydeficiency AT kristinhicks 605nhsil12plusentinostatcombinationeffectivelytargetsantipd1pdl1checkpointresistantmurinetumorsharboringmhcclassiandantigenprocessingmachinerydeficiency |